NCT00486187 Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study Status COMPLETED Phase NA
NCT00485732 A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years Status COMPLETED Phase PHASE3
NCT00485069 REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study Status COMPLETED Phase PHASE4
NCT00484874 Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00483899 Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects Status COMPLETED Phase PHASE1
NCT00483860 A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function Status COMPLETED Phase PHASE1
NCT00483600 Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction Status WITHDRAWN Phase NA
NCT00482391 Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer Status COMPLETED Phase PHASE2
NCT00481767 Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age. Status COMPLETED Phase PHASE3
NCT00481429 Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study Status WITHDRAWN Phase N/A
NCT00481390 Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients Status COMPLETED Phase N/A
NCT00481182 Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study. Status COMPLETED Phase PHASE1
NCT00480649 Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS) Status COMPLETED Phase PHASE4
NCT00480324 Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants Status COMPLETED Phase PHASE3
NCT00480025 GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT00479856 Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer Status TERMINATED Phase PHASE2
NCT00479739 CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca. Status COMPLETED Phase PHASE4
NCT00479427 A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis Status COMPLETED Phase PHASE2